Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
chronic pain
Biotech
Lilly buys 4E to beef up its non-opioid pain pipeline
The deal gives Lilly a pipeline of early-stage non-opioid therapeutics targeting the MNK-eIF4E signaling pathway in peripheral sensory neurons.
Angus Liu
Jun 16, 2026 2:34pm
Medtronic inks $650M deal for SPR Therapeutics
May 20, 2026 4:54pm
AbbVie inks $745M deal with China’s Haisco for two pain assets
Apr 13, 2026 9:48am
Eli Lilly sidelines pain prospect in another pipeline shift
Oct 30, 2025 2:19pm
Okyo's eye drops reduce neuropathic eye pain in phase 2 win
Jul 16, 2025 11:57am
Lilly lands next-gen pain asset in $1B SiteOne acquisition
May 27, 2025 11:30am
